Skip to main content

Diagnostic Yield of Genetic Testing in Adults with Ataxia: a Decade of Experience at the Johns Hopkins Ataxia Center

In brief

Genetic testing identified an ataxia cause in 4 of 10 adults

At one specialist center, testing diagnosed 204 of 510 adults with ataxia evaluated from 2014 to 2024; SCA27B was the most common finding. A family history of ataxia was linked to higher diagnostic yield, but these retrospective results from a referred patient group may not reflect outcomes in other settings.

Journal
Cerebellum (London, England) (Q1)
Published
20 November 2026
Study design
Retrospective cohort
Evidence level
Level 3, Low (CEBM 3b)
Authors
Makenna May, Hadley Bryan, Karen S Raraigh, Ashley Kucharski, Toluwani Olarinde, Jee Bang, et al.
PMID
43062742
DOI
10.1007/s12311-026-02118-8

Why clinicians should know about it

  • Picked for Genetics (clinical) (paper of the day, 21 November 2026): Decade-long clinical cohort reports genetic diagnostic yield in adult ataxia

Abstract

This retrospective study describes the diagnostic yield of genetic testing in adults with ataxia who were evaluated at the Johns Hopkins Ataxia Center from 2014 to 2024. The Johns Hopkins Ataxia Center (JHAC) outlined a comprehensive genetic testing algorithm for completing genetic testing in 2014, which has been revised over time to reflect updates in the field. Most recently, genome sequencing, with the ability to detect repeat expansions, is recommended as the first-line genetic test in the absence of a known familial pathogenic variant. Electronic medical records of all adult patients who completed genetic counseling at the JHAC from 2014 to 2024 were retrospectively analyzed. Data extraction included: 1) clinical data pertaining to ataxia diagnosis and phenotype, including standardized ratings scales (i.e., Scale for the Assessment and Rating of Ataxia [SARA] and Montreal Cognitive Assessment [MoCA]), age of symptom onset, and presence of family history; 2) diagnostic genetic tests ordered and resulted; and 3) demographic information, including self-reported biological sex, race and ethnicity, and education level. Of the 750 patients referred for genetic counseling at the JHAC during this time, 510 underwent genetic testing as part of their workup. A total of 204 (40%) of patients received a genetic diagnosis. The most frequently identified genetic diagnosis in our cohort was SCA27B, accounting for 32 probands (14.7% of cohort). The second most frequently identified genetic diagnosis was SCA6 in 25 probands (12.3% of cohort). Individuals with a family history of ataxia were 3.47 times more likely to receive a genetic diagnosis. Individuals with vestibular dysfunction were 1.54 times more likely to receive a genetic diagnosis. Developmental delay/intellectual disability, cognitive decline, spasticity, parkinsonism, and cerebellar atrophy had no significant associations with diagnostic yield, although the presence of parkinsonism does approach significance (p-value = 0.061). The molecular diagnosis of hereditary ataxias has long been a significant challenge. At the JHAC, a genetic work-up, with current first-line testing of genome sequencing, was valuable to integrate into clinical practice.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.